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ABSTRACT 
 
The present study investigated the ameliorative properties of Diospyroschloroxylon (methanolic) leaf extract 
(DCLE) in liver of rats intoxicated with N-Nitrosodimethylamine (NDMA). Antioxidant markers- Superoxide 
dismutase (SOD), catalase (CAT), reduced glutathione (GSH) and lipid peroxidation were assayed 
spectrophotometrically. DNA fragmentation was determined spectrophotometrically. The Bcl-2, Ki-67 and CD15 
markers were assayed using immunohistochemistry. The activities of SOD and catalase were decreased in the 
NDMA-treated rats by 99.5% and 47.1%, respectively compared with controls, whereas pretreatment with DCLE 
showed significantly elevated (p < 0.05) values as against NDMA. NDMA treatment reduced GSH level by 35.7% 
compared with controls, while DCLE pretreatment significantly increased the level relative to NDMA group. The 
NDMA significantly increased (p < 0.05) MDA level with the value 3.56 ± 1.07 (µM of MDA/mg protein) as 
against the control (1.83 ± 0.14 µM of MDA/mg protein). On pretreatment with DCLE, the level was observed to be 
1.99 ± 0.77 µM of MDA/mg protein. NDMA treatment significantly increased DNA fragmentation in the liver by 
122.2% relative to control rats, while DCLE pretreatment reduced the level by 77.9% compared with NDMA 
treatment. The NDMA caused strong expressions of Bcl-2, Ki-67 and CD15 relative to controls, while DCLE 
supplementation ameliorated the effects. The findings suggest that Diospyroschloroxylon methanol leaf extract 
possesses hepatoprotective properties expressed through the amelioration of oxidative stress, cell proliferation and 
malignancy in liver of rats treated with N-Nitrosodimethylamine. 
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Introduction 
N-Nitrosodimethylamine (NDMA) is a potent toxic 
compound unintentionally formed during various 
industrial manufacturing processes, from where it 
becomes introduced into the environment [1]. Studies 
have established the presence of this compound in foods, 
drinking water, ground water and wastewater [2]. N-
Nitrosamines are mutagenic and are capable of generating 
deleterious radicals in cellular systems [3]. However, 
these compounds can also be synthesized in man as a 
result of nitrosation of nitrosable precursors in diets, 
drinking water, drugs and tobacco smoke [4, 5]. In 
mammalian cells, NDMA is metabolically demethylated 
via a cytochrome P-450-dependent initial α-hydroxylation 
reaction to form methyldiazohydroxide[6, 7]. The  
_______________________________ 
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methyldiazohydroxide is finally converted to 
methyldiazonium ion, which can methylate DNA and 
other macromolecules to initiate carcinogenesis [8]. It has 
been shown that the metabolism of N- nitrosamines could 
generate a high level of nitric oxide [9]. Earlier studies 
have revealed the generation of reactive oxygen species 
(ROS) during cellular metabolism of N-nitrosamines 
which may lead to formation of reactive oxygen species 
(ROS), which could trigger tumor development [10, 11] 
and immunoregulation[12].Diospyrosis a large genus of 
trees or shrubs, belonging to family Ebenaceae, which are 
widely distributed all over the world. Phytoconstituents of 
Diospyrosrange from hydrocarbons, long chain fatty acids 
to steroids, terpenoids, naphthoquinones, and naphthalene-
based aromatics and aurones. The leaves are used in curing 
several diseases including boils, pains, swelling and skin 
diseases, to mention a few [13]. However, the fruits of some 
Diospyros species contain some chemicals useful as fish 
poisoning or for medicinal purposes, although the 
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active components are yet to be identified [14]. Earlier 
phytochemical studies of leaf extracts of 
Diospyroschloroxylon indicated the presence of a 
broad spectrum of secondary metabolites, such as 
cardiac glycosides, alkaloids, flavonoids, tannins, 
amino acids and proteins and saponins[15]. In a 
phytochemical study, it was reported that acetone 
extract of D. chloroxylon contained secondary 
metabolites such as terpenoids, alkaloids, tannins, 
phenols and saponins, while the aqueous and ethanol 
extracts were found to contain quinones, amino acids 
and proteins [16].  An important triterpene, known as 
betulinic acid, has been reported to have several 
biological properties, and is present in 
Diospyrosleucomelas[17]. The presence of these 
secondary metabolites in plants is an indication that 
plants are potential sources of useful 
phytomedicines[18]. The medicinal uses and chemical 
composition of various Diospyros species have been 
reviewed [19], and several metabolites in Diospyros 
species like ursolic acid have been found to exhibit an 
inhibitory potential against HIV-1 protease, while 
others, such as diospyrin, amytrin and betulin were 
found to be cytotoxic against many cancers [20]. 
Information on the activity of Diospyroschloroxylon 
against N-Nitrosodimethylamine intoxication was 
scarce in literature, the present study was therefore 
designed to investigate the activities of 
Diospyroschloroxylon in rats treated with 
intraperitoneal administration of NDMA.      
Materials and method 
Chemicals 
N-Nitrosodimethylamine and methanol were 
purchased from Sigma Aldrich (St. Loius, MO, USA). 
All other chemicals and reagents used in this study 
were commercially available and are of analytical 
grade. 
Plant material 
The leaves ofDiospyroschloroxylonpurchased from a 
local herb vendor in Ogbomoso, Nigeria, were 
authenticated at the Department of Biology, Botany 
Unit, Ladoke Akintola University of Technology, 
Ogbomoso, and a voucher specimen was deposited in 
the herbarium.  
Extraction 
The collected leaves were rinsed with distilled water, 
air dried and powered using an electrical blender. The 
powered leaf was soaked in methanol and allowed to 
stand for 72 hours. This process of extraction was 
repeated twice and the extract was collected, filtered 
and concentrated under vacuum using rotary 
evaporator at 45
o
C. The crude extract obtained was 
used for the study. 
 
Experimental Design 
Twenty four male Wistar rats of an average weight of 
140 ± 26 g were purchased from the Institute of 
Advanced Medical Research and Training (IAMRAT) 
Animal House, University College Hospital (UCH) 
Ibadan, Oyo State, Nigeria. The animals were 
randomly divided into four groups having six rats per 
group and then housed in cages and fed ad libitum 
with rat pellets and distilled water under 12- hours 
light/dark cycle at room temperature. The rats were 
acclimatized for one week. Control group was given 
normal rat pellets and water. The DCLE group was 
given daily oral intubation of Diospyroschloroxylon 
(methanolic) leaf extract (DCLE) (100 mg/kg) for 14 
days. The N-Nitrosodimethylamine  (NDMA) group 
was treated with intraperitoneal injection of NDMA at 
5 mg/kg (
1
/5
th
 LD50) twice per week, while NDMA + 
DCLE group was administered with daily oral 
intubation of DCLE (100 mg/kg) for 14 days and 
intraperitoneal injection of NDMA (5 mg/kg) twice 
per week.  After 14 days of treatment, rats were fasted 
overnight and weighed. Blood was collected by ocular 
bleeding and rats were sacrificed by cervical 
dislocation. 
Collection of blood and liver  
Blood was collected by ocular bleeding into test tubes, 
allowed to coagulate, and supernatant was centrifuged 
at 3000rpm for 10 minutes to obtain the serum which 
was kept under refrigeration (4
o
C) for biochemical 
analysis.  Liver was excised, washed in 1.15% KCl 
solution (washing buffer) to remove blood and then 
weighed. The organ was divided into two portions. 
One portion was preserved in 10% formalin for 
immunohistochemical study, while the other portion 
was homogenized with Teflon homogenizer in 0.01M 
Phosphate buffer solution (pH 7.4). It was then 
centrifuged at 3000rpm for 10minutes to obtain 
supernatant which was used for the determination of 
biochemical parameters. 
Biochemical assays 
Total protein assay  
Total protein concentrations of serum and liver were 
determined using Lowry’s method [21]. 
Assay of Superoxide dismutase (SOD) activity  
Superoxide dismutase activity in liver homogenate 
was determined by the epinephrine method, 
measuring the absorbance at 480nm as previously 
described [22]. 
Assay of Catalase (CAT) activity 
Catalase activity in liver homogenate was 
spectrophotometrically determined, measuring the 
absorbance at 240nm according[23]. 
Assay of Malondialdehyde (MDA) level 
Lipid peroxidation in liver homogenate was estimated 
by determining the concentration of malondialdehyde 
(MDA). The measurement of MDA involved taking 
the absorbance of Thiobarbituric acid-reacting 
substances (TBARS) at 532nm [24].  The MDA 
concentration was calculated using a molar extinction 
coefficient (Ɛ) of 1.56 x 10
5
 M
-1
cm
-1
.  
Assay of Reduced Glutathione (GSH) 
Reduced Glutathione level in liver homogenate was 
determined, measuring the absorbance at 412nm as 
previously described [25].  
 
DNA Fragmentation by Diphenylamine (DPA) 
Assay 
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The colorimetric determination of fragmented DNA 
was done according to the method described by Wu et 
al. [26] with some modifications. The liver was 
homogenized in Tris-EDTA (TE) buffer and then 
centrifuged at 27000 x g for 10 minutes, to separate 
the intact DNA (pellet) from the fragmented DNA 
(supernatant). Both the pellet and supernatant were 
treated with freshly prepared DPA reagent for colour 
development. Incubation was carried out at 37
0
c for 
16-24 hours. The absorbance was read 
spectrophotometrically at 620nm. The percentage 
fragmented DNA was calculated using the formula: 
Fragmented DNA= Absorbance of supernatant 
                             Absorbance of pellet +                             
Absorbance of supernatant         
 
 
Immunohistochemical (IHC) assays 
Immunochemical studies of liver sections for 
expressions of Bcl-2, Ki-67 and CD15 were carried 
out according to Chakravarthiet al. [27] with 
modifications as briefly described below. The 
deparaffinized liver sections were subjected to the 
peroxidase labeled streptavidin-biotin technique, 
using the monoclonal antibodies against Bcl-2, Ki-67 
and CD15 antigens. Peroxidase blocking was carried 
out on the sections by covering the sections with 3% 
hydrogen peroxide for 15 minutes. The sections were 
washed with phosphate buffered saline (PBS) and 
protein blocking was done using avidin for 15 
minutes. The sections were washed with PBS and 
endogenous biotin in the liver was blocked for 15 
minutes, followed by incubation with 5μg/ml each of 
anti-Bcl-2, anti-Ki-67 and anti-CD15 antibodies 
(diluted in 1:100) for 60 minutes. PBS was used to 
wash excess antibodies followed by application of 
secondary antibodies (LINK) on the sections for 15 
minutes. The sections were washed and Horseradish 
peroxidase (HRP) label was applied on the sections 
for 15 minutes, and then washed with PBS for 5 
minutes to remove unbound HRP. Visualization of the 
reaction products was done by immersing the section 
in Karnovsky solution (0.01% diaminobenzidine in 
Tris buffer containing 0.05% hydrogen peroxide and 
0.01% sodium azide). Excess diaminobezidine (DAB) 
solution and precipitate were washed off with distilled 
water. The tissue sections were counterstained with 
Haematoxylin solution for 2 minutes. The slides were 
dehydrated in alcohol, cleaned in xylene, mounted in 
DPX mountant and then observed under 
microscope.Cells with specific brown colour in the 
cytoplasm, cell membrane or nuclei, depending on the 
antigenic sites, were considered positive. 
Statistical Analysis 
Data are expressed in Mean ± SD. Student T-test 
analysis was used for statistical comparison and 
differences were taken as significant at p < 0.05. 
Descriptive and graphical methods were used to 
characterize the data. 
Results 
The data in Table 1 indicate that NDMA increased 
weight gain in the rats by 22.8% when compared with 
the control rats. However, a combination of DCLE 
with NDMA showed that the weight gain was lowered 
(86.7%) relative to the NDMA-treated rats.  The 
treatment showed no significant differences in the 
weight and relative weight of liver of the rats.    
 
Table 1: Effects of DCLE on body weight and relative weights of liver of rats treated with NDMA 
 
Treatments Weight of rats (g) Weight of liver 
(g) 
Relative weight 
of liver (%) 
Initial Final Weight Gain 
Control 138.70 ±22.4 170.92 ±11.60 32.22 ±1.42 4.47 ± 0.64 2.62 ± 0.14 
DCLE 141.34 ±40.2 172.00 ± 6.47 30.66 ± 3.13 5.31± 0.50 3.08 ± 0.18 
NMDA 140.17±19.27 179.72± 19.80 39.55 ±1.78* 5.23 ± 0.45 2.91 ± 0.45 
DCLE + NMDA 143.40±24.50 164.59± 12.89 21.19 ± 2.98** 5.54 ± 0.23 3.36 ± 0.14 
Data are expressed as means ± SD (n= 5).  Value with * is significantly different (p< 0.05) when compared with 
control while ** signifies significant difference (p< 0.05) compared with NDMA-group.  
DCLE – Diospyroschloroxylon leaf extract, NDMA- N-Nitrosodimethylamine 
 
Table 2 shows the effect of the different treatments on protein concentrations in the serum and liver of the rats. 
NDMA treatment  was observed to significantly increase (p < 0.05) the serum and liver protein levels compared 
with controls, while pre-treatment with DCLE lowered the levels by 99.1% and 48.7%, respectively, compared 
with NDMA group.  
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Table 2: Effect of DCLE on total protein concentrations of serum and liver in rats treated with NDMA 
 
Treatments Serum (µmol/dL) Liver (µmol/dL) 
Control  29.51 ± 1.17 33.60 ± 4.17 
DCLE 32.01± 7.28 24.09 ± 1.66 
NDMA 39.34 ± 4.30
*
 51.30 ± 1.83
*
 
DCLE + NMDA 19.76 ± 4.14
**
 34.49 ± 8.10
**
 
 
Data are expressed as means ± SD (n= 5).  Value 
with * is significantly different (p< 0.05) when 
compared with control while ** signifies 
significant difference (p< 0.05) compared with 
NDMA-group.  
DCLE – Diospyroschloroxylon leaf extract, 
NDMA- N-Nitrosodimethylamine;. As shown in 
Table 3, the activities of both superoxide dismutase 
(SOD) and catalase (CAT) were decreased in the 
NDMA-treated rats by 99.5% and 47.1%, 
respectively in liver, whereas pretreatment with 
DCLE elevated the activities by 59% and 89.7%, 
respectively in comparison with the rats 
administered with NDMA. The level of (GSH) in 
the hepatic tissue was noticed to significant 
decrease (p < 0.05) in the NDMA group compared 
with controls. On pretreatment with DCLE, the 
level was found to increase by 51.5% when 
compared with the NDMA-treated rats (Table 3). 
As also shown in table 3, NDMA significantly 
increased (p < 0.05) the level of lipid peroxidation 
measured as  malondialdehyde (MDA) in the rats 
with the value 3.56 ± 1.07(µM of MDA/mg 
protein) as against the control (1.83 ± 0.14 µM of 
MDA/mg protein). On pretreatment with DCLE, 
the level was observed to be 1.99 ± 0.77 µM of 
MDA/mg protein. This result shows that NDMA 
increased the MDA level by 94.5% compared with 
controls, while pretreatment with DCLE reduced 
the level by 78.9%, relative to NDMA-treated rats. 
Table 3: Effects of DCLE on antioxidant indices in liver of rats treated with NDMA 
Treatments         SOD 
(U/mg protein) 
CAT 
(U/mg protein 
GSH 
(U/mg protein) 
MDA 
(µM of MDA/mg 
protein 
Control 7.50 ± 0.45 6.25 ± 1.33 13.75 ± 2.11 1.83 ± 0.14 
DCLE 9.23 ± 1.12 5.45 ± 0.22 11.67 ± 0..98 2.15 ± 0.76 
NDMA 3.76 ± 0.19* 4.25 ± 1.00* 10.13 ± 1.21* 3.56 ± 1.07* 
DCLE + NDMA 5.98 ± 0.23** 8.06 ± 2.65** 15.35 ± 1.88** 1.99  ± 0.77** 
 
Data are expressed as means ± SD (n= 5).  Value 
with * is significantly different (p< 0.05) when 
compared with control while ** signifies 
significant difference (p< 0.05) compared with 
NDMA-group.  
DCLE – Diospyroschloroxylon leaf extract, 
NDMA- N-Nitrosodimethylamine 
Figure 1 depicts the effect of DCLE on DNA 
fragmentation in liver of rats treated with 
NDMA.DNA fragmentation in the hepatic tissue 
was significantly increased by  NDMA (90.43 ± 
1.71 %) compared with controls (40.70 ± 1.15 %). 
On pretreatment with DCLE, it was found that 
DNA fragmentation decreased significantly (50.83 
± 3.11%) against NDMA effect in the experimental 
rats. This result has therefore revealed that NDMA 
treatment significantly increased DNA 
fragmentation in the liver by 122.2 % relative to 
control rats, while DCLE pretreatment reduced the 
level by 77.9% compared with NDMA treatment. 
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Figure 1: Effects of DCLE on DNA fragmentation in liver of rats treated with NDMA 
Data are expressed as means ± SD (n= 5).  Value with * is significantly different (p< 0.05) when compared with 
control while ** signifies significant difference (p< 0.05) compared with NDMA-group.  
 
DCLE – Diospyroschloroxylon leaf extract, NDMA- N-Nitrosodimethylamine 
Immunohistochemical examination results for Bcl-2, Ki-67 and CD15 expressions in liver are shown in figures 
2, 3 and 4, respectively. Bcl-2 was expressed at a moderate level in both the control and DCLE groups (Fig. 2A 
and 2B, respectively), while NDMA treatment resulted in a pronounced expression of the same (Fig. 2C). This 
was however, attenuated in the NDMA + DCLE group by pre-treatment with DCLE (Fig. 2D).  
 
 
 
Figure 2: Hepatic Expression of Bcl-2 in rats treated with NDMA and DCLE 
 
This trend was observed in hepatic expressions of Ki-67 and CD15 in the rats. The control group displayed very 
low expression of Ki-67 (Fig. 3A) while the DCLE group expressed the protein at a mild rate (Fig. 3B). On the 
other hand, NDMA caused a marked increase in its expression (Fig. 3C), which was drastically reduced by 
DCLE treatment (Fig. 3D).  
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Figure 3: Hepatic Expression of Ki-67 in rats treated with NDMA and DCLE 
Similarly, CD15 was mildly expressed in the control and DCLE groups (Fig. 4A and 4B), but NDMA treatment 
resulted in a marked production of the protein (Fig. 4C)which was reduced in the NDMA + DCLE group to 
level comparable to the control (Fig. 4D). 
 
 
Figure 4: Hepatic Expression of CD15 in rats treated with NDMA and DCLE 
 
Discussion 
 
Human exposures to nitrosable precursors in diets, 
tobacco smoke and drinking water serve as potential 
sources of nitrosamines [28, 29, 30, 31]. These 
compounds have been found to be highly mutagenic 
and are capable of generating free radicals in living 
cells [32, 33]. The carcinogenic potential of 
nitrosamines has been implicated in several cancers 
[34, 35]. Having discovered a paucity of information 
on the effects of Diospyroschloroxylon on NDMA 
toxicity, we therefore designed the study to investigate 
the possible ameliorative potential of this plant in rats 
intoxicated with NDMA. The data presented show 
that NDMA elevated weight gain in the rats by 22.8% 
relative to the control rats.  
When the rats were pretreated with DCLE, the weight 
gain was decreased by 86.7% as against the NDMA-
treated rats. However, the treatment has no significant 
effects on the weight and relative weight of liver of 
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the rats. In contrast to our observation in the present 
study, Sivaramakrishnanet al. [36] and Singh et al. 
[37] reported body weight loss after administration of 
N-nitrosodiethylamine (NDEA). The NDMA was 
noticed to significantly increase (p < 0.05) the serum 
and liver protein levels compared with controls, while 
the pre-treatment with DCLE lowered the levels by 
99.1% and 48.7%, respectively, compared with 
NDMA group. Oxidative stress (OS) occurs when the 
reactive oxygen species (ROS) are not 
counterbalanced by the cellular antioxidant defense 
system, which may lead to the oxidation of DNA, 
protein or lipid molecules and several events, such as, 
altered gene expression [38], enhanced cell 
proliferation [39], genomic or chromosome instability, 
genetic mutation or tumor development [40, 41]. The 
activities of both superoxide dismutase and catalase 
were decreased in the NDMA-treated rats by 99.5% 
and 47.1%, respectively in the hepatic tissue, whereas 
a pre-treatment with DCLE was found to elevate the 
activities by 59% and 89.7%, respectively as against 
the effect of NDMA. N-Nitrosamines such as N-
Nitrosodibutylamine (NDBA), N-Nitrosodiethylamine 
(NDEA) and NDMA have been observed to reduce 
the activity of SOD in experimental animals [37, 42]. 
SOD converts the highly reactive superoxide radical 
to hydrogen peroxide, which later becomes detoxified 
by either catalase or glutathione peroxidase [43]. 
Reduced activities of SOD and catalase could be due 
to continuous production of superoxide radicals, 
hydrogen peroxide and other toxic metabolites, which 
are accumulated, leading to deleterious effects, such 
as loss of cell membrane integrity, membrane function 
and oxidative stress [44, 45]. However, a low SOD 
activity may result in elevated level of superoxide 
anion which in turn leads to low Nitric Oxide (NO) 
level, but increased peroxy-nitrite level, due to 
increased interaction between superoxide anion and 
nitric oxide. An elevated SOD activity has been 
noticed in Down’s syndrome, while a decreased 
activity has been observed in diabetes, Alzheimer’s 
disease, rheumatoid arthritis, Parkinson’s disease, 
uremic anaemia, atherosclerosis and thyroid 
dysfunction [45]. Catalase detoxifies hydrogen 
peroxide to oxygen and water [46, 47], thereby 
enhancing acquisition of tolerance to oxidative stress 
as a form of cellular adaptive response [43]. The level 
of (GSH) in the hepatic tissue was noticed to 
significant decrease (p < 0.05) in the NDMA group 
compared with controls. On pre-treatment with 
DCLE, the level was found to increase by 51.5% 
when compared with the NDMA-treated rats. 
Reduced glutathione is a low molecular weight thiol 
antioxidant, serving as a substrate for glutathione 
peroxidase (GPX), an enzyme that detoxifies lipid 
peroxides and hydrogen peroxide (H2O2), associated 
with oxidative stress. During detoxification of 
toxicants, GSH is oxidized to glutathione disulfide 
(GSSG), which is converted back to the reduced form 
(GSH) by glutathione reductase (GPR). A reduced 
GSH level has been associated with low level of 
cysteine molecules needed for GSH biosynthesis, 
which in turn may be a result of liver damage [48]. In 
the course of N-nitrosamines metabolism, nitric oxide 
is produced in excess [9], leading to ROS generation 
and initiation of neoplasm and tumorigenesis [49, 10, 
11]. NDEA- and NDMA-induced carcinogenesis in 
rats has been associated with GSH depletion [50, 37, 
42], which could be as a result of an impairment of 
GSH synthesis [51]. Pretreatment with GSH before 
administration of either NDMA or NDEA ameliorated 
the depletion of GSH and induction of free radicals in 
mice [50], suggesting that GSH counteracts the toxic 
effects of these nitrosamines by directly scavenging 
the free radicals generated. However, GSH could also 
initiate the repair of oxidative damage [52]. The 
treatment with NDMA was also observed to 
significantly elevate (p < 0.05) the level of 
malondialdehyde (MDA) in the rats but  pretreatment 
with DCLE considerably reduced it to a level 
comparable to the control .N-Nitrosamines such as, 
NDEA [42], NDMA [10] and BBN [9] have been 
found to elevate MDA level during liver 
carcinogenesis. Lipid peroxidation (LPO) end-
products, including malondialdehyde (MDA) and 4-
hydroxy-2-nonenal (4-HNE) are electrophiles capable 
of interacting with DNA and proteins to initiate 
mutagenesis [53]. The MDA forms MDA-DNA 
adducts which induce frame shift mutations in DNA 
sequences leading to genetic instability, a process that 
has emerged as a possible direct link between 
oxidative stress and human cancinogenesis[54, 55]. 
The NDMA significantly elevated the DNA 
fragmentation in the hepatic tissue compared with 
controls. On pretreatment with DCLE, it was found 
that DNA fragmentation decreased significantly 
against NDMA effect in the experimental rats. This 
result has therefore revealed that NDMA treatment 
significantly increased DNA fragmentation in the liver 
relative to control rats, while DCLE pretreatment 
significantly reduced the level compared with NDMA 
treatment. The significantly high levels of DNA 
fragmentation in NDMA–treated rats compared with 
DCLE-pretreated rats, as observed in the present 
study, may imply that nitrosamine could cause 
diseases such as Alzheimer’s disease (AD), Parkinson 
disease, amyotrophic lateral sclerosis and spinal 
muscular atrophy associated with excessive 
(pathologic) apoptosis [56]. In addition, dysregulation 
of apoptosis seems to be directly linked to other 
human diseases including cancer, autoimmune 
diseases, and neuronal degeneration [57]. 
 The immunohistochemical analysis revealed that 
NDMA caused a strong expression of Bcl-2 protein in 
the liver relative to the control rats, while 
supplementation with DCLE resulted in moderate 
expression of the antiapoptotic protein compared with 
the NDMA-treated rats, The major physiological 
function of anti-apoptotic Bcl-2 is to maintain an 
antiapoptotic potential that prevents the action of 
proapoptotic proteins involved in the formation of 
mitochondrial membrane permeability transition pore 
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[58]. In addition to the mitochondrial action, Bcl-2 has 
also been reported to act at the endoplasmic reticulum 
(ER), where the antiapoptotic protein modulates 
Ca
2+
signalling, thereby promoting proliferation, while 
increasing resistance to apoptosis [59]. The dynamic 
balance between Bcl-2 (antiapoptotic) and the 
proapoptotic members significantly determines 
whether a cell commits to initiation of apoptosis or 
not [60, 61].  
       In the present study, however, the down-
regulation of this antiapoptotic protein on DCLE 
supplementation could be due to the up-regulation of 
the proapoptotic proteins, antagonizing the Bcl-2 
effect. The present study has observed a strong 
expression of Ki-67 protein, a marker of cell 
proliferation in clinical studies, in the liver of rats 
treated with NDMA as against the control rats-
However, on supplementation with DCLE, mild to 
moderate expression of this protein was observed in 
comparison with the NDMA- treated rats.  
 
                     The Ki-67 is a nuclear protein being 
associated with cell proliferation, and usually 
expressed in every active part of the cell cycle (G1, S, 
G2 and M), but absent in resting (quiescent) cells (G0) 
[62, 63]. Although the staining of Ki-67 commonly 
appears nucleolar or peri-nucleolar, it has also been 
shown to be associated with ribosomal RNA 
transcription and inactivation of Ki-67 protein may 
lead to inhibition of ribosomal RNA synthesis [64]. 
Ki-67 over- expression is frequently seen in a variety 
of malignant tissues and is associated with worse 
survival of individuals with a neuro-endocrine tumour 
[65]. 
 
                             The result obtained from this study 
has therefore, indicated the possibility of NDMA to 
induce malignancy in liver, since a strong expression 
of Ki-67 was observed in the group treated with this 
compound, whereas DCLE showed an ameliorative 
tendency. The immunohistochemical staining of the 
liver section showed that NDMA caused hyperplasia 
with high expression of CD15, while a moderate 
expression was noticed in the rats pre-treated with 
DCLE.The CD15 antigen (3-fucosyl-N-acetyl-
lactosamine) is an extracellular carbohydrate adhesion 
molecule, belonging to the selectin family, found on 
the surface of glycoproteins of the plasma membrane 
of neutrophils and monocytes [66].  
 
                   This carbohydrate antigen plays a role as a 
marker of extracellular adhesion and migration of 
cells. Adhesion molecules are involved in cell-to-cell 
communication, which is an important factor, not only 
in tissue development and organization, but also in 
several other functions in multicellular organisms [67] 
(Larson and Springer, 1990).  
                            The growth of many cancers 
depends on self-renewing cells called stem cells or 
tumor propagating cells (TPCs), to which strong 
activity of CD15 molecule has been associated [68]. A 
relationship has been observed between the expression 
of CD15 antigen and intrahepatic metastasis in 
hepatocellular carcinoma (HCC) [69]. The present 
finding may therefore suggest that NDMA could 
induce metastasis in the hepatic tissue. In conclusion, 
the present study depicts methanol leaf extract 
ofDiospyroschloroxylon displaying potential 
hepatoprotective property by reversing and stabilizing 
NDMA-induced disruption of the antioxidant defense 
system in rats. In addition, the plant extract displayed 
ability to attenuate DNA fragmentation, reduce cell 
proliferation and malignancy resulting from NDMA 
treatment in rats. Further studies are required to 
elucidate the different phytochemicals responsible for 
the properties exhibited by Diospyroschloroxylon. 
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